A Tale of Two Sides: Sabre/Farelogix in the United States and the U.K.
The authors discuss the differing conclusions of the U.S. and U.K. courts in the proposed Sabre/Farelogix merger.
Evaluating Innovation Theories of Harm in Merger Review: Economic Frameworks and Difficulties
The authors discuss recent life science cases that deal with innovation theories of harm, and what economic models can be useful in reviewing proposed mergers in this space.
No-Poach Clauses in QSR Litigation
Class certification was denied in two seminal franchise no-poach litigation matters involving McDonald’s and Jimmy John’s.
Hussein v. QSI et al.
The jury awarded our clients a complete defense verdict in the first case involving a “holder’s claim” to reach trial in California.
Who’s Who Legal: Competition Future Leaders—Economists 2021
Cornerstone Research in-house experts recognised as future leaders of the international competition community.
Who’s Who Legal: Competition 2021—Economists
Cornerstone Research staff and affiliated experts were selected for the 2021 list of ‘the best consultants, expert witnesses and advisers in the world.’
Cornerstone Research Connects: SEC Cryptocurrency Enforcement—Q3 2013–Q4 2020
The authors discuss key trends of the SEC’s enforcement actions against digital asset market participants.
Securities Class Action Filings—2021 Midyear Assessment
Plaintiffs filed 112 new securities class action lawsuits in federal and state courts in the first half of 2021.
Number of Securities Class Action Filings Falls to Lowest Level Since 2015
SPAC-related filings increase sharply in first half of 2021.
Federal Trade Commission v. 1-800 Contacts
The Second Circuit Court of Appeals overturned an FTC decision regarding trademark enforcement against online competitors.
2021 Diversity Forum and Sophomore Experience
Cornerstone Research offered career development programs for first- and second-year undergraduate students interested in applying their academic studies to real-world challenges.
Cornerstone Research Staff and Experts Submit Comments to Multilateral Pharmaceutical Merger Task Force
Comments emphasize the need for the FTC to consider the varied effects of mergers on innovation.
How can we help you?
If you are looking for a publication not on our website, contact us.